Aventis buys time in tussle with Sanofi

Aventis has bought itself up to three months' respite from the €48bn ($59bn) hostile bid from Sanofi-Synthélabo by resorting to the French legal system.

The Paris appeals court will hear two cases linked to the bid on May 6 against the Autorité des Marchés Financiers (AMF), France's financial regulator.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump